Clinical Trials Directory

Trials / Completed

CompletedNCT02122406

Depression and Anxiety in Rheumatoid Arthritis

Depression and Anxiety in Rheumatoid Arthritis: Prevalence and Relation With Disease Activity

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
University of Pavia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary endpoint of this study is to evaluate the prevalence of anxiety and depressive disorders, and their relationship with disease activity, in patients with rheumatoid arthritis treated with biological drugs

Detailed description

The prevalence of anxiety and depressive disorders will be assesed with the HADS questionnaire at the time of the visit

Conditions

Interventions

TypeNameDescription
OTHERHospital Anxiety and Depression Scale (HADS) questionnairePatients filled in the Hospital Anxiety and Depression Scale (HADS) questionnaire

Timeline

Start date
2014-01-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2014-04-24
Last updated
2016-10-10
Results posted
2016-10-10

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02122406. Inclusion in this directory is not an endorsement.